Profile | GDS845 / 2115 |
Title | Breast cancer cell line ME16C response to chemotherapeutics: time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM11707 | ME16C, 12h, sham | -0.173 | 43 |
GSM11716 | ME16C, 12h, sham B | -0.312 | 34 |
GSM11850 | ME16C, 24h, sham B | 0.561 | 80 |
GSM11851 | ME16C, 24h, sham | 0.256 | 68 |
GSM11721 | ME16C, 36h, sham B | 0.242 | 64 |
GSM11852 | ME16C, 36h, sham | -0.138 | 35 |
GSM11694 | ME16C, 12h, 0.5uM DOX B | -0.087 | 45 |
GSM11695 | ME16C, 12h, 0.5uM DOX | -0.131 | 41 |
GSM11734 | ME16C, 24h, 0.5uM DOX | -1.387 | 18 |
GSM11861 | ME16C, 24h, 0.5uM DOX B | 0.303 | 65 |
GSM11843 | ME16C, 36h, 0.5uM DOX | 0.125 | 55 |
GSM11862 | ME16C, 36h, 0.5uM DOX B | 0.496 | 76 |
GSM11697 | ME16C, 12h, 0.06mM 5FU | -0.688 | 12 |
GSM11714 | ME16C, 12h, 0.06mM 5FU B | -0.274 | 39 |
GSM11723 | ME16C, 24h, 0.06mM 5FU | 0.409 | 70 |
GSM11845 | ME16C, 24h, 0.06mM 5FU B | 0.06 | 51 |
GSM11683 | ME16C, 36h, 0.06mM 5FU | -0.12 | 45 |
GSM11691 | ME16C, 36h, 0.06mM 5FU B | -0.193 | 37 |